Myocardial protection with phosphocreatine in high-risk cardiac surgery patients: a randomized trial

Myocardial protection with phosphocreatine in high-risk cardiac surgery patients: a randomized trial

Abstract Background This study was conducted to test the hypothesis that phosphocreatine (PCr), administered intravenously and as cardioplegia adjuvant in patients undergoing cardiac surgery with prolonged aortic cross clamping and cardiopulmonary bypass (CPB) time, would decrease troponin I concent...

Full description

Bibliographic Details
Main Authors: Vladimir Lomivorotov, Dmitry Merekin, Evgeny Fominskiy, Dmitry Ponomarev, Alexander Bogachev-Prokophiev, Anton Zalesov, Alexander Cherniavsky, Anna Shilova, Dmitry Guvakov, Liudmila Lomivorotova, Rosalba Lembo, Giovanni Landoni
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Anesthesiology
Subjects:
Anesthesia
Intensive care
Phosphocreatine
Cardiopulmonary bypass
Valve heart surgery
Troponin
Online Access:https://doi.org/10.1186/s12871-023-02341-4

Internet

https://doi.org/10.1186/s12871-023-02341-4

Similar Items